Guizhou Sanli Pharmaceutical (SHA:603439) proposed to withdraw its holdings in associate Ya Zun Bao Digital Technology, bringing down its registered capital by 53.6 million yuan, according to a Shanghai bourse filing on Wednesday.
Ya Zun Bao's registered capital will decline to 26.4 million yuan from 80 million yuan.
The pharmaceutical company's shares rose less than 3% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments